HVTN 141/ HPTN 105

A phase 1 clinical trial to evaluate the safety, tolerability, pharmacokinetics and in vitro neutralization of VRC01.23LS, ePGDM1400v9-LS and ePGT121v1-LS alone and in combination in healthy, HIV-uninfected adult participants

August 2022 (AIDS 2022) update: Trial announced; Protocol currently in development. See June 2022 HPTN trial sheet for more information here

*Not yet on ClinicalTrials.gov as of August 2022

Last updated August 10, 2022